Why we still use intravenous drugs as the basic regimen for neurosurgical anaesthesia

Current Opinion in Anaesthesiology

Volumn 19, Issue 5, 2006, Pages 498-503

  Hans, Pol ^a,b   Bonhomme, Vincent ^a  

^a Centre Hospitalier Regional de La Citadelle   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Intravenous agents; Neurosurgery; Neurosurgical anaesthesia; Propofol

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHALATION ANESTHETIC AGENT; ISOFLURANE; PROPOFOL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SEVOFLURANE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN ELECTROPHYSIOLOGY; BRAIN METABOLISM; BRAIN TUMOR; CLINICAL TRIAL; CRANIOTOMY; ENDOSCOPIC SURGERY; EVOKED AUDITORY RESPONSE; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; HUMAN; HYPERTENSION; HYPERVENTILATION; INFLAMMATION; INTRACRANIAL HYPERTENSION; INTRAOPERATIVE PERIOD; INTRAVENOUS ANESTHESIA; JUGULAR VEIN; MINIMALLY INVASIVE SURGERY; NERVE CELL LESION; NEUROPROTECTION; NEUROSURGERY; OXYGEN SATURATION; PERFUSION PRESSURE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; STEREOTAXIC SURGERY;

ANESTHESIA; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INTRAVENOUS; ANIMALS; BRAIN; CONSCIOUS SEDATION; CRANIOTOMY; HUMANS; MONITORING, PHYSIOLOGIC; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; NEUROSURGICAL PROCEDURES; PROPOFOL;

EID: 33748674023     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000245274.69292.ad     Document Type: Review

References (54)

1. Petersen KD, Landsfeldt U, Cold GE, et al. Intracranial pressure and cerebral hemodynamic in patients with cerebral tumors: a randomized prospective study of patients subjected to craniotomy in propofol-fentanyl, isoflurane-fentanyl, or sevoflurane-fentanyl anesthesia. Anesthesiology 2003; 98:329-336.
2. Kolbitsch C, Lorenz IH, Hormann C, et al. A subanesthetic concentration of sevoflurane increases regional cerebral blood flow and regional cerebral blood volume and decreases regional mean transit time and regional cerebrovascular resistance in volunteers. Anesth Analg 2000; 91:156-162.
3. Ogawa Y, Iwasaki K, Shibata S, et al. The effect of sevoflurane on dynamic cerebral blood flow autoregulation assessed by spectral and transfer function analysis. Anesth Analg 2006; 102:552-559.
4. Kaisti KK, Langsjo JW, Aalto S, et al. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 2003; 99:603-613.
5. Marval PD, Perrin ME, Hancock SM, Mahajan RP. The effects of propofol or sevoflurane on the estimated cerebral perfusion pressure and zero flow pressure. Anesth Analg 2005; 100:835-840. Propofol and sevoflurane have opposite effects on the cerebral vasculature. Estimated cerebral perfusion pressure decreases with propofol and is maitained with sevoflurane. In hypocapnic conditions, the zero flow pressure increases with sevoflurane, but is maintained under propofol anaesthesia.
6. Munoz HR, Nunez GE, de la Fuente JE, Campos MG. The effect of nitrous oxide on jugular bulb oxygen saturation during remifentanil plus target-controlled infusion propofol or sevoflurane in patients with brain tumors. Anesth Analg 2002; 94:389-392.
7. Kawano Y, Kawaguchi M, Inoue S, et al. Jugular bulb oxygen saturation under propofol or sevoflurane/nitrous oxide anesthesia during deliberate mild hypothermia in neurosurgical patients. J Neurosurg Anesthesiol 2004; 16:6-10.
8. Iwata M, Kawaguchi M, Inoue S, et al. Effects of increasing concentrations of propofol on jugular venous bulb oxygen saturation in neurosurgical patients under normothermic and mildly hypothermic conditions. Anesthesiology 2006; 104:33-38. Changes in propofol concentrations do not affect jugular venous bulb oxygen saturation values as long as propofol is administered in dosages commonly used in clinical practice.
9. Girard F, Moumdjian R, Boudreault D, et al. The effect of propofol sedation on the intracranial pressure of patients with an intracranial space-occupying lesion. Anesth Analg 2004; 99:573-577.
10. Sneyd JR, Andrews CJ, Tsubokawa T. Comparison of propofol/remifentanil and sevoflurane/remifentanil for maintenance of anaesthesia for elective intracranial surgery. Br J Anaesth 2005; 94:778-783.
11. Zhang J, Liang WM. Effects of volatile anesthetics on cortical somatosensory evoked potential and bispectral index. Zhonghua Yi Xue Za Zhi 2005; 85:2700-2703.
12. Clapcich AJ, Emerson RG, Roye DP, et al. The effects of propofol, small-dose isoflurane, and nitrous oxide on cortical somatosensory evoked potential and bispectral index monitoring in adolescents undergoing spinal fusion. Anesth Analg 2004; 99:1334-1340.
13. Liu EH, Wong HK, Chia CP, et al. Effects of isoflurane and propofol on cortical somatosensory evoked potentials during comparable depth of anaesthesia as guided by bispectral index. Br J Anaesth 2005; 94:193-197. At comparable depth of anaesthesia guided by the bispectral index, propofol compared to isoflurane, causes less suppression of cortical somatosensory evoked potentials with better preservation of amplitude and less variability.
14. Murrell JC, De Groot HN, Psatha E, Hellebrekers LJ. Investigation of changes in the middle latency auditory evoked potential during anesthesia with sevoflurane in dogs. Am J Vet Res 2005; 66:1156-1161.
15. Chen Z. The effects of isoflurane and propofol on intraoperative neurophysiological monitoring during spinal surgery. J Clin Monit Comput 2004; 18:303-308.
16. Erb TO, Ryhult SE, Duitmann E, et al. Improvement of motor-evoked potentials by ketamine and spatial facilitation during spinal surgery in a young child. Anesth Analg 2005; 100:1634-1636.
17. Hargreaves SJ, Watt JW. Intravenous anaesthesia and repetitive transcranial magnetic stimulation monitoring in spinal column surgery. Br J Anaesth 2005; 94:70-73.
18. Journee HL, Polak HE, de Kleuver M, et al. Improved neuromonitoring during spinal surgery using double-train transcranial electrical stimulation. Med Biol Eng Comput 2004; 42:110-113.
19. Lyon R, Feiner J, Lieberman JA. Progressive suppression of motor evoked potentials during general anesthesia: the phenomenon of 'anesthetic fade'. J Neurosurg Anesthesiol 2005; 17:13-19. A prolonged exposure to anaesthetic agents necessitates higher stimulation thresholds to elicit motor evoked responses, independently of the dose-depressant effect. Recognition of anaesthetic fade is essential when interpreting motor evoked potentials under general anaesthesia.
20. Gerlach K, Uhlig T, Huppe M, et al. Remifentanil-propofol versus sufentanil-propofol anaesthesia for supratentorial craniotomy: a randomized trial. Eur J Anaesthesiol 2003; 20:813-820.
21. Magni G, Baisi F, La Rosa I, et al. No difference in emergence time and early cognitive function between sevoflurane-fentanyl and propofol-remifentanil in patients undergoing craniotomy for supratentorial intracranial surgery. J Neurosurg Anesthesiol 2005; 17:134-138.
22. Weninger B, Czerner S, Steude U, Weninger E. Comparison between TCI-TIVA, manual TIVA and balanced anaesthesia for stereotactic biopsy of the brain. Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39:212-219.
23. Gupta A, Stierer T, Zuckerman R, et al. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg 2004; 98:632-641; table.
24. Bernstein M. Outpatient craniotomy for brain tumor: a pilot feasibility study in 46 patients. Can J Neurol Sci 2001; 28:120-124.
25. Yamamoto F, Kato R, Sato J, Nishino T. Anaesthesia for awake craniotomy with noninvasive positive pressure ventilation. Br J Anaesth 2003; 90:382-385.
26. Hans P, Bonhomme V, Born JD, et al. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anaesthesia 2000; 55:255-259.
27. Berkenstadt H, Perel A, Hadani M, et al. Monitored anesthesia care using remifentanil and propofol for awake craniotomy. J Neurosurg Anesthesiol 2001; 13:246-249.
28. Sarang A, Dinsmore J. Anaesthesia for awake craniotomy - evolution of a technique that facilitates awake neurological testing. Br J Anaesth 2003; 90:161-165.
29. Fukaya C, Katayama Y, Yoshino A, et al. Intraoperative wake-up procedure with propofol and laryngeal mask for optimal excision of brain tumour in eloquent areas. J Clin Neurosci 2001; 8:253-255.
30. Keifer JC, Dentchev D, Little K, et al. A retrospective analysis of a remifentanil/propofol general anesthetic for craniotomy before awake functional brain mapping. Anesth Analg 2005; 101:502-508. This retrospective study considers continuous infusion of remifentanil/propofol as a satisfactory anaesthetic technique in patients undergoing awake craniotomy, but emphasizes the risk of brief episodes of apnea and transient arterial hypertension.
31. Soriano SG, Eldredge EA, Wang FK, et al. The effect of propofol on intraoperative electrocorticography and cortical stimulation during awake craniotomies in children. Paediatr Anaesth 2000; 10:29-34.
32. Himmelseher S, Pfenninger E. Anaesthetic management of neurosurgical patients. Curr Opin Anaesthesiol 2001; 14:483-490.
33. Lim YJ, Zheng S, Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 2004; 100:562-568.
34. Kato R, Ross S, Foex P. Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br J Anaesth 2000; 84:204-214.
35. Mathy-Hartert M, Mouithys-Mickalad A, Kohnen S, et al. Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia 2000; 55:1066-1071.
36. Acquaviva R, Campisi A, Murabito P, et al. Propofol attenuates peroxynitrite-mediated DNA damage and apoptosis in cultured astrocytes: an alternative protective mechanism. Anesthesiology 2004; 101:1363-1371.
37. Thiry JC, Hans P, Deby-Dupont G, et al. Propofol scavenges reactive oxygen species and inhibits the protein nitration induced by activated polymorphonuclear neutrophils. Eur J Pharmacol 2004; 499:29-33.
38. Peters CE, Korcok J, Gelb AW, Wilson JX. Anesthetic concentrations of propofol protect against oxidative stress in primary astrocyte cultures: comparison with hypothermia. Anesthesiology 2001; 94:313-321.
39. Daskalopoulos R, Korcok J, Farhangkhgoee P, et al. Propofol protection of sodium-hydrogen exchange activity sustains glutamate uptake during oxidative stress. Anesth Analg 2001; 93:1199-1204.
40. Ozturk E, Demirbilek S, Kadir BA, et al. Antioxidant properties of propofol and erythropoietin after closed head injury in rats. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:922-927.
41. Adembri C, Venturi L, Tani A, et al. Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology 2006; 104:80-89. This experimental study shows that propofol, at clinically relevant concentrations, is neuroprotective in models of cerebral ischaemia in vitro and in vivo, and that it could act by preventing the increase in neuronal mitochondrial swelling.
42. Balyasnikova IV, Visintine DJ, Gunnerson HB, et al. Propofol attenuates lung endothelial injury induced by ischemia-reperfusion and oxidative stress. Anesth Analg 2005; 100:929-936. The capacity of propofol to attenuate the lung endothelial injury induced by ischaemia-reperfusion is clearly related to its antioxidant properties.
43. Engelhard K, Werner C, Eberspacher E, et al. Influence of propofol on neuronal damage and apoptotic factors after incomplete cerebral ischemia and reperfusion in rats: a long-term observation. Anesthesiology 2004; 101:912-917.
44. Ke QB, Hou J, Chen C, et al. Effect of propofol on spinal cord apoptosis associated with aortic cross-clamping in rabbits. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005; 17:426-429.
45. Bayona NA, Gelb AW, Jiang Z, et al. Propofol neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks. Anesthesiology 2004; 100:1151-1159.
46. Acquaviva R, Campisi A, Raciti G, et al. Propofol inhibits caspase-3 in astroglial cells: role of heme oxygenase-1. Curr Neurovasc Res 2005; 2:141-148. The beneficial effect of propofol on peroxynitrite-induced apoptosis of astroglial cells appears to be mediated by an increase in heme oxygenase expression.
47. Engelhard K, Werner C, Eberspacher E, et al. Sevoflurane and propofol influence the expression of apoptosis-regulating proteins after cerebral ischaemia and reperfusion in rats. Eur J Anaesthesiol 2004; 21:530-537.
48. Luo T, Xia Z, Ansley DM, et al. Propofol dose-dependently reduces tumor necrosis factor-alpha-induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth Analg 2005; 100:1653-1659. Propofol, at clinically relevant concentrations, significantly and dose-dependently attenuates TNF-induced increase in the apoptosis index and decrease in Bcl-2/Bax ratio in cultured human umbilical vein endothelial cells.
49. Kotani N, Hashimoto H, Sessler DI, et al. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg 1999; 89:1250-1256.
50. Gilliland HE, Armstrong MA, Carabine U, McMurray TJ. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth Analg 1997; 85:1394-1398.
51. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000; 31:2325-2329.
52. Kazmierski R, Guzik P, Ambrosius W, et al. Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clin Neurol Neurosurg 2004; 107:38-43.
53. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996; 347:422-425.
54. Feng CS, Ma HC, Yue Y, et al. Effect of propofol on the activation of nuclear factor-kappa B and expression of inflammatory cytokines in cerebral cortex during transient focal cerebral ischemia-reperfusion: experiment with rats. Zhonghua Yi Xue Za Zhi 2004; 84:2110-2114.